Arena Pharmaceuticals to Present Additional PreClinical Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at European Society of Cardiology Congress

SAN DIEGO Aug. 22 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA will present additional detailed preclinical pharmacology and pharmacokinetic data on ralinepag APD811 the Company's nextgeneration oral selective prostacyclin receptor IP agonist in...